{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:49:08Z","timestamp":1788536948139,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04232-9","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T12:57:16Z","timestamp":1745153836000},"page":"160-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy assessment of repeat iodine-131 treatment in patients with papillary thyroid carcinoma assessed as biochemical incomplete response"],"prefix":"10.1007","volume":"89","author":[{"given":"Zilin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"key":"4232_CR1","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1089\/thy.2015.0116","volume":"25","author":"S Vaccarella","year":"2015","unstructured":"S. Vaccarella, L. Dal Maso, M. Laversanne, F. Bray, M. Plummer, S. Franceschi, The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid 25, 1127\u20131136 (2015).","journal-title":"Thyroid"},{"key":"4232_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"4232_CR3","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1210\/jc.2010-2708","volume":"96","author":"M Brassard","year":"2011","unstructured":"M. Brassard, I. Borget, A. Edet-Sanson, A.L. Giraudet, O. Mundler, M. Toubeau, F. Bonichon, F. Borson-Chazot, L. Leenhardt, C. Schvartz, C. Dejax, I. Brenot-Rossi, M.E. Toubert, M. Torlontano, E. Benhamou, M. Schlumberger, T.W. Group, Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J. Clin. Endocrinol. Metab. 96, 1352\u20131359 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4232_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1530\/EJE-11-0466","volume":"165","author":"MG Castagna","year":"2011","unstructured":"M.G. Castagna, F. Maino, C. Cipri, V. Belardini, A. Theodoropoulou, G. Cevenini, F. Pacini, Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients. Eur. J. Endocrinol. 165, 441\u2013446 (2011).","journal-title":"Eur. J. Endocrinol."},{"key":"4232_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","volume":"34","author":"Y Ito","year":"2010","unstructured":"Y. Ito, A. Miyauchi, H. Inoue, M. Fukushima, M. Kihara, T. Higashiyama, C. Tomoda, Y. Takamura, K. Kobayashi, A. Miya, An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J. Surg. 34, 28\u201335 (2010).","journal-title":"World J. Surg."},{"key":"4232_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1\u2013133 (2016).","journal-title":"Thyroid"},{"key":"4232_CR7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2010.0178","volume":"20","author":"RM Tuttle","year":"2010","unstructured":"R.M. Tuttle, H. Tala, J. Shah, R. Leboeuf, R. Ghossein, M. Gonen, M. Brokhin, G. Omry, J.A. Fagin, A. Shaha, Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 20, 1341\u20131349 (2010).","journal-title":"Thyroid"},{"key":"4232_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s12020-019-02142-1","volume":"67","author":"J Ahn","year":"2020","unstructured":"J. Ahn, E. Song, W.G. Kim, T.Y. Kim, W.B. Kim, Y.K. Shong, M.J. Jeon, Long-term clinical outcomes of papillary thyroid carcinoma patients with biochemical incomplete response. Endocrine 67, 623\u2013629 (2020).","journal-title":"Endocrine"},{"key":"4232_CR9","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1089\/thy.2014.0043","volume":"24","author":"RC Smallridge","year":"2014","unstructured":"R.C. Smallridge, N. Diehl, V. Bernet, Practice trends in patients with persistent detectable thyroglobulin and negative diagnostic radioiodine whole body scans: a survey of American Thyroid Association members. Thyroid 24, 1501\u20131507 (2014).","journal-title":"Thyroid"},{"key":"4232_CR10","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1210\/jcem.86.9.7831","volume":"86","author":"F Pacini","year":"2001","unstructured":"F. Pacini, L. Agate, R. Elisei, M. Capezzone, C. Ceccarelli, F. Lippi, E. Molinaro, A. Pinchera, Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients. J. Clin. Endocrinol. Metab. 86, 4092\u20134097 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4232_CR11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1089\/thy.2011.0522","volume":"22","author":"RP Padovani","year":"2012","unstructured":"R.P. Padovani, E. Robenshtok, M. Brokhin, R.M. Tuttle, Even without additional therapy, serum thyroglobulin concentrations often decline for years after total thyroidectomy and radioactive remnant ablation in patients with differentiated thyroid cancer. Thyroid 22, 778\u2013783 (2012).","journal-title":"Thyroid"},{"key":"4232_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-2265.2012.04342.x","volume":"77","author":"F Vaisman","year":"2012","unstructured":"F. Vaisman, D. Momesso, D.A. Bulzico, C.H. Pessoa, F. Dias, R. Corbo, M. Vaisman, R.M. Tuttle, Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. Clin. Endocrinol. 77, 132\u2013138 (2012).","journal-title":"Clin. Endocrinol."},{"key":"4232_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27736","volume":"10","author":"C Lu","year":"2024","unstructured":"C. Lu, N. Han, J. Li, G. Wang, C. Wang, Q. Jia, J. Tan, X. Wang, Z. Meng, Prognostic factors for postoperative papillary thyroid cancer with unexplained elevated Tg: A retrospective study. Heliyon 10, e27736 (2024).","journal-title":"Heliyon"},{"key":"4232_CR14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s12020-021-02647-8","volume":"73","author":"MY Tramontin","year":"2021","unstructured":"M.Y. Tramontin, G.M. Nobre, M. Lopes, M.P. Carneiro, P.A.G. Alves, F.A. de Andrade, F. Vaisman, R. Corbo, D. Bulzico, High thyroglobulin and negative whole-body scan: no long-term benefit of empiric radioiodine therapy. Endocrine 73, 398\u2013406 (2021).","journal-title":"Endocrine"},{"key":"4232_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1210\/jc.2009-1567","volume":"95","author":"WG Kim","year":"2010","unstructured":"W.G. Kim, J.S. Ryu, E.Y. Kim, J.H. Lee, J.H. Baek, J.H. Yoon, S.J. Hong, E.S. Kim, T.Y. Kim, W.B. Kim, Y.K. Shong, Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan. J. Clin. Endocrinol. Metab. 95, 1169\u20131173 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4232_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/thy.2013.0427","volume":"24","author":"PW Rosario","year":"2014","unstructured":"P.W. Rosario, G.F. Mourao, J.B. dos Santos, M.R. Calsolari, Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin?. Thyroid 24, 533\u2013536 (2014).","journal-title":"Thyroid"},{"key":"4232_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.clon.2010.05.005","volume":"22","author":"M Chao","year":"2010","unstructured":"M. Chao, Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan. Clin. Oncol. 22, 438\u2013447 (2010).","journal-title":"Clin. Oncol."},{"key":"4232_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/105072503321582060","volume":"13","author":"SJ Mandel","year":"2003","unstructured":"S.J. Mandel, L. Mandel, Radioactive iodine and the salivary glands. Thyroid 13, 265\u2013271 (2003).","journal-title":"Thyroid"},{"key":"4232_CR19","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/sj.bjc.6601319","volume":"89","author":"C Rubino","year":"2003","unstructured":"C. Rubino, F. de Vathaire, M.E. Dottorini, P. Hall, C. Schvartz, J.E. Couette, M.G. Dondon, M.T. Abbas, C. Langlois, M. Schlumberger, Second primary malignancies in thyroid cancer patients. Br. J. Cancer 89, 1638\u20131644 (2003).","journal-title":"Br. J. Cancer"},{"key":"4232_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08292-8","volume":"21","author":"X Mei","year":"2021","unstructured":"X. Mei, X. Yao, F. Feng, W. Cheng, H. Wang, Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients. BMC Cancer 21, 543 (2021).","journal-title":"BMC Cancer"},{"key":"4232_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12020-014-0213-2","volume":"46","author":"RM Tuttle","year":"2014","unstructured":"R.M. Tuttle, Optimal management of a biochemical incomplete response to therapy in differentiated thyroid cancer: aggressive treatment or cautious observation?. Endocrine 46, 363\u2013364 (2014).","journal-title":"Endocrine"},{"key":"4232_CR22","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.3390\/cancers13215422","volume":"13","author":"M Steinschneider","year":"2021","unstructured":"M. Steinschneider, J. Pitaro, S. Koren, Y. Mizrakli, C. Benbassat, L. Muallem Kalmovich, Differentiated thyroid cancer with biochemical incomplete response: clinico-pathological characteristics and long term disease outcomes. Cancers 13, 5422 (2021).","journal-title":"Cancers"},{"key":"4232_CR23","doi-asserted-by":"publisher","first-page":"17319","DOI":"10.1007\/s00432-023-05439-x","volume":"149","author":"KC Sproll","year":"2023","unstructured":"K.C. Sproll, I. Hermes, G. Felder, N.H. Stoecklein, M. Seidl, P. Kaiser, W. Kaisers, Comparative analysis of diagnostic ultrasound and histopathology for detecting cervical lymph node metastases in head and neck cancer. J. Cancer Res. Clin. Oncol. 149, 17319\u201317333 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"4232_CR24","first-page":"e7122","volume":"12","author":"A Shokoohi","year":"2020","unstructured":"A. Shokoohi, E. Berthelet, S. Gill, E. Prisman, G. Sexsmith, E. Tran, A. White, S.M. Wiseman, J. Wu, C. Ho, Treatment for recurrent differentiated thyroid cancer: a Canadian population based experience. Cureus 12, e7122 (2020).","journal-title":"Cureus"},{"key":"4232_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12020-015-0823-3","volume":"54","author":"L Lamartina","year":"2016","unstructured":"L. Lamartina, T. Montesano, F. Trulli, M. Attard, M. Torlontano, R. Bruno, D. Meringolo, F. Monzani, S. Tumino, G. Ronga, M. Maranghi, M. Biffoni, S. Filetti, C. Durante, Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients. Endocrine 54, 467\u2013475 (2016).","journal-title":"Endocrine"},{"key":"4232_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.diii.2021.04.004","volume":"102","author":"E Zampella","year":"2021","unstructured":"E. Zampella, M. Klain, L. Pace, A. Cuocolo, PET\/CT in the management of differentiated thyroid cancer. Diagn. Interv. Imaging 102, 515\u2013523 (2021).","journal-title":"Diagn. Interv. Imaging"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04232-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04232-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04232-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T06:49:21Z","timestamp":1751611761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04232-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["4232"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04232-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,20]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethics approval was granted by the Ethics Committee of the ethics committee of Tianjin Medical University General Hospital (approval number: IRB-2024-YX-183-01, retrospectively registered).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}